Company Overview and News

LRT-1 operator seeks gov’t approval to raise fares

2018-05-22 bworldonline
THE Light Rail Manila Corp. (LRMC) is seeking to raise fares at the Light Trail Transit Line 1 (LRT-1) by P5 to P7 in August.

MPIC weighs options on Singapore power unit

The group led by businessman Manuel V. Pangilinan is rethinking options on the 800-megawatt natural gas-fired combined cycle facility in Jurong, Singapore, following a power supply glut that has affected the entire power-generation space in the city-state.

Meralco, First Pacific weighing options for Singapore power plant

2018-05-20 bworldonline
METRO PACIFIC Investments Corp. Chief Finance Officer David J. Nicol said the group is assessing options for a liquefied natural gas (LNG) power plant owned by its unit Manila Electric Co. (Meralco) and parent First Pacific Ltd. in Singapore, where a surplus in power capacity has put a pressure on prices.

MPIC power businesses target 1,600-MW hike in capacity by 2022

2018-05-18 bworldonline
THE power units of Metro Pacific Investments Corp. (MPIC) will be expanding their capacity by around 1,600 megawatts (MW) until 2022, with plans to invest around P30 billion during the period.

MPIC posts ‘better-than-expected’ Q1 earnings

2018-05-03 bworldonline
METRO PACIFIC Investments Corp. (MPIC) grew first-quarter earnings by 16% on the back of better-than-expected volume growth in its business units, as the infrastructure conglomerate remains hopeful of reaching an acceptable agreement with the government on its long-pending tariff issues.

MPIC proposes tollway project in Malaysia

2018-04-22 bworldonline
METRO PACIFIC Investments Corp. (MPIC) has submitted a bid for a tollway project in Malaysia, eyeing to close an agreement for the venture within the year.

RHI sees lower sugar production this year

2018-04-11 bworldonline
INTEGRATED sugar and ethanol producing firm Roxas Holdings, Inc. (RHI) anticipates lower sugar production this year.

MPCALA taps Leighton for Cavite segment of CALAX

2018-04-09 bworldonline
MPCALA HOLDINGS, Inc. has tapped Leighton Asia to build the Cavite segment of the Cavite-Laguna Expressway (CALAX).

Forex loss and income tax weigh down PXP Energy

2018-02-28 bworldonline
PXP ENERGY Corp. posted a bigger consolidated net loss of P39.1 million in 2017, weighed down by foreign exchange losses and higher tax provision, the company told the stock exchange on Wednesday.

New SCTEx, NLEx junctions seen to improve safety, access

2018-02-26 bworldonline
NLEX CORP. yesterday formally opened the Subic-Clark-Tarlac Expressway (SCTEx) Mabiga interchange and the North Luzon Expressway (NLEx) Sta. Ines-Magalang exit.

LRMC taps Voith to repair trains

2018-02-22 bworldonline
LIGHT RAIL Manila Corp. (LRMC) has signed a P450-million agreement with Voith Digital Solutions Austria GmBH and Co KG for the rehabilitation and upgrade of Light Rail Transit-1 (LRT-1) generation-2 trains.

MPIC hopes to get original proponent status for CTBEx

2018-02-11 bworldonline
THE METRO PACIFIC group is expected to secure original proponent status (OPS) for the Cavite-Tagaytay-Batangas Expressway (CTBEx) this month.

RHI narrows net loss in Q1

2018-02-08 bworldonline
ROXAS HOLDINGS, Inc. (RHI) narrowed its net loss by 2% during the first quarter of crop year 2018, as revenues surged on higher volume of sugar sold.

CALAEx Laguna Blvd-Mamplasan section to open by December

2018-02-08 bworldonline
THE LAGUNA Boulevard to Mamplasan section of the Cavite-Laguna Expressway (CALAEx) can be opened by December, according to Department of Public Works and Highways (DPWH) Secretary Mark A. Villar.

Construction of LRT extension to Cavite possible by midyear

2018-02-02 bworldonline
LIGHT RAIL Manila Corp. (LRMC) may start by midyear the construction of the Light Rail Transit (LRT)-1 extension to Cavite.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...